U.S. Court of Appeals for the Federal Circuit
Ibsa Institut Biochimique v. Teva Pharmaceuticals USA
This writing
- Type
- Opinion
- Filed
- July 31, 2020
- Case
- Ibsa Institut Biochimique v. Teva Pharmaceuticals USA
- Case status
- Decided
Source No authoring judge could be established for this writing, either from provider metadata or from the signature line of the court's published opinion. Benchlight shows the gap rather than guessing at an author.
Opening text
The first passage of the document, as extracted by the source provider.
Case: 19-2400 Document: 41 Page: 1 Filed: 07/31/2020 United States Court of Appeals for the Federal Circuit ______________________ IBSA INSTITUT BIOCHIMIQUE, S.A., ALTERGON, S.A., IBSA PHARMA INC., Plaintiffs-Appellants v. TEVA PHARMACEUTICALS USA, INC., Defendant-Appellee ______________________ 2019-2400 _____________…
Source Extract supplied by CourtListener. Benchlight does not host the document — read the authoritative text in the court's own PDF.